MNA
WST icon

Manning & Napier Advisors’s West Pharmaceutical WST Stock Holding History

Manning & Napier Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30
Closed -$7.87K – 607
2025
Q3 		$7.87K Buy
+30
New +$7.29K ﹤0.01% 409

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Manning & Napier Advisors's WST Position: Q4 2025 in Review

Manning & Napier Advisors sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 30 shares — an estimated $7.87K sold.

Manning & Napier Advisors first reported a position in WST in Q3 2025 and held it in 1 quarter. The position peaked at $7.87K in Q3 2025. 803 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Manning & Napier Advisors reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Manning & Napier Advisors sold 30 West Pharmaceutical shares in Q4 2025, an estimated $7.87K.
  • Manning & Napier Advisors first reported a position in West Pharmaceutical in Q3 2025 and held it in 1 quarter.
  • Manning & Napier Advisors's West Pharmaceutical position peaked at $7.87K in Q3 2025.
  • 803 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Manning & Napier Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.